SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000799698-17-000037
Filing Date
2017-11-08
Accepted
2017-11-07 18:08:01
Documents
3
Period of Report
2017-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DISCLOSURE OF STRATEGIC REALIGNMENT OF DRUG DEVELOPMENT ACTIVITIES form8k_11082017.htm 8-K 18580
2 PRESS RELEASE DATED NOVEMBER 6, 2017 exh99_1.htm EX-99.1 26953
3 image00001.jpg GRAPHIC 2863
  Complete submission text file 0000799698-17-000037.txt   50906
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 171184620
SIC: 2836 Biological Products, (No Diagnostic Substances)